NCT01936896View on ClinicalTrials.gov

Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Acute Myocardial Infarction
Interventions
DRUG

Alpha 1-Antitrypsin

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT01936896 - Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter